. . . "Humans and other mammals"@en . . . . . . . . . . . . "investigational"@en . "2-Diethylaminoethyl p-aminobenzoate"@en . . . "4-Aminobenzoic acid 2-diethylaminoethyl ester"@en . . " "@en . . . . . "Procaine"@en . "59-46-1"@en . . . . "Procainum"@en . "beta-(Diethylamino)ethyl 4-aminobenzoate"@en . . . . . . . "Procaine acts mainly by inhibiting sodium influx through voltage gated sodium channels in the neuronal cell membrane of peripheral nerves. When the influx of sodium is interrupted, an action potential cannot arise and signal conduction is thus inhibited. The receptor site is thought to be located at the cytoplasmic (inner) portion of the sodium channel. Procaine has also been shown to bind or antagonize the function of N-methyl-D-aspartate (NMDA) receptors as well as nicotinic acetylcholine receptors and the serotonin receptor-ion channel complex."@en . . . "Vitamin H3"@en . . "\u03B2-(diethylamino)ethyl p-aminobenzoate"@en . . . . . "With normal kidney function, the drug is excreted rapidly by tubular excretion."@en . . . . "Procaine"@en . . "# Gentry CL, Lukas RJ: Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes. J Pharmacol Exp Ther. 2001 Dec;299(3):1038-48. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11714893"@en . . . . "\u03B2-(diethylamino)ethyl 4-aminobenzoate"@en . . . . . . . . . . "approved"@en . . . . . "Procaina"@en . . . . "p-Aminobenzoic acid 2-diethylaminoethyl ester"@en . . . . . . . . "beta-(Diethylamino)ethyl P-aminobenzoate"@en . "A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016). [PubChem]"@en . . . "7.7 minutes"@en . . "Used as a local anesthetic primarily in oral surgery"@en . . . . . . . . . . . "Novocaine"@en . . " "@en . . .